Home
About ArLAR
About Kuwait
Congress Venue
Hotel, Tours & Dinners
Information
ArLAR 25 Congress
Committees
ArLAR23 Kuwait Organizing Committee
ArLAR23 Kuwait Scientific Committee
ArLAR Executive Council
ArLAR Board Of Directors
ArLAR Scientific Committee
ArLAR Francophone Group
ArLAR PRAG Executive Board Committee
ArLAR Special Interest Groups – SIG
ArLAR23 Sessions
Program
Abstracts
Workshops
Speakers
Workshops Speakers
Sessions Speakers
Partners
Sponsors
Supporters
Registration
Promote
Arlar
Home
/
Abstract
/
Bisphosphonates therapy for osteoporosis in women with breast cancer: a 6-year follow up
Bisphosphonates therapy for osteoporosis in women with breast cancer: a 6-year follow up
admin
Effects of zolendronic acid on bone mineral density in patients with osteoporosis treated for breast cancer
Previous post
EVALUATION OF THERAPEUTIC RESPONSE TO CORTICOSTEROID INJECTIONS IN LUMBORADICULALGIA AND CARPAL TUNNEL SYNDROME.
Next post
admin
(Website)
administrator
This website is supported by
